the pangea model: a novel dynamic model used to define disease progression in multiple myeloma
Published 1 year ago • 194 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
1:21
rationale behind the development of the novel dynamic pangea model
-
3:24
an update on the pangea model
-
5:04
the pangea model: improving risk stratification in multiple myeloma
-
1:51
key features of the pangea model: improving risk stratification in myeloma
-
1:11
the pangea model: enhancing risk assessment for individuals with high-risk smoldering myeloma
-
9:30
the evolution of technology: from the wheel to ai
-
1:00:30
metabolomics analysis 2023 | 08: integrating metabolomics with other omics
-
39:33
new advances in single-cell and spatial genomics (2024)
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
1:32
epigenetic drivers of disease progression in multiple myeloma
-
2:12
using a novel machine learning model to analyze and predict the outcomes of patients with ndmm
-
3:19
development of a novel next generation myeloma-specific liquid biopsy approach
-
4:01
kenneth anderson: what are the next steps to a myeloma cure?
-
1:37
mrd in myeloma
-
1:01
car-t: myeloma toxicities
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
2:46
managing patients with high-risk myeloma
-
1:53
the future of multiple myeloma treatment
-
1:21
what is the pcrowd study, and how does knowledge in myeloma biology help with new treatments?
-
5:02
drug resistance in multiple myeloma
-
2:17
mutations found in myeloma patients
-
0:57
the potential of the tsafinder tool in hematological oncology